Sign Up to Receive Your Personalised Learning Resources
JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Niraparib as first-line maintenance treatment in ovarian cancer
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
Precision oncology – predicting future risk in early breast cancer (eBC)
Focus on leukemia – Felix and ASC4FIRST
Durvalumab for the Treatment of Advanced Biliary Tract Cancer
FUTURE LEADERS: Connecting medicine and humanity with Dr Eric Lander
Capivasertib + paclitaxel for metastatic triple-negative breast cancer did not meet threshold for improving overall survival
What’s new in primary ITP? Key updates from ASH 2024
Foreword – touchREVIEWS in Oncology & Haematology, Volume 20, Issue 2, 2024
Project Cure CRC ignites innovation in 2025 with $10.5 million in research, K-SPY debut & renewed RFP
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Futibatinib for the Treatment of Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma with Fibroblast Growth Factor Receptor 2 (FGFR2) Gene Fusions or Other Rearrangements
View
Dostarlimab for the Treatment of Endometrial Cancer: A Review
View
Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma: From optimal sequencing to shared decision-making
View
Precision oncology – predicting future risk in early breast cancer (eBC)
View
Looking to the future in the treatment of steroid-refractory chronic GvHD
View
Capivasertib + paclitaxel for metastatic triple-negative breast cancer did not meet threshold for improving overall survival
View
PARP inhibitors for metastatic castration-resistant prostate cancer: Enhancing patient–practitioner conversations
View
FUTURE LEADERS: Shaping the future of cancer treatment with Dr Yuri Yoshinami
View
Trastuzumab Deruxtecan for the Treatment of HER2-low Advanced or Metastatic Breast Cancer
View
Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
